Search…

"Chia Tai Tianqing Biological: Recombinant herpes zoster vaccine approved for clinical trials."

09/07/2025

Chia Tai Tianqing Bio Announcement, the recombinant herpes zoster vaccine developed by its wholly-owned subsidiary Chia Tai Longkema has obtained the Drug Clinical Trial Approval Notice from the National Medical Products Administration, approving the clinical trial for the prevention of herpes zoster in individuals aged 40 and above.

Latest

2 m ago

Youjia Innovation (02431.HK) completed the placement of 6.8 million shares and will increase investment in advanced driver assistance systems and L4 autonomous driving.

4 m ago

Dalicap (Stock Code: 301566.SZ) shareholder Panxin Investment intends to reduce its shareholding by up to 4.5%.

4 m ago

Guangfa Securities (01776.HK) plans to issue short-term corporate bonds of no more than 3 billion RMB.

5 m ago

Intelligent start-up company Inceptio recently completed a $122 million angel round of financing. This round of financing was led by Meituan's investment arm, followed by Junshan Investment, Bihong Investment, Guoqi Investment, Lingang Science and Technology Innovation Investment, Sequoia Capital China, and Jianfa Emerging Investment. Existing shareholders Linear Capital and Xianghe Capital also increased their investment in this round. When asked to confirm the information, Inceptio's financing manager and Chief Strategy Officer Vincent said, "The news is true." (LatePost)

5 m ago

Startup company Embodied Intelligence, co-founded by Vishal Sikka, completes a $122 million angel round financing.

See all latest